Fariba Navid, MD
Fariba Navid, MD, joined the Children’s Center for Cancer and Blood Diseases in September, 2016 as assistant director of the Clinical Trials Program and COG Phase I & Pilot Consortium. She is also an associate professor of Clinical Pediatrics at the Keck School of Medicine, University of Southern California. Navid has extensive experience in research and pediatric early-phase drug development, and joined CHLA from St. Jude Children’s Research Hospital.
Education
Tulane Medical School, New Orleans, Louisiana
Rainbow Babies and Childrens Hospital, Case Western Reserve University, Cleveland, Ohio
Rainbow Babies and Childrens Hospital, Case Western Reserve University, Cleveland, Ohio
Clinical Fellow, Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD
Accomplishments
Pediatrics - October, 1992 (recertified January, 2000)
Pediatric Hematology/Oncology - November, 1998 (recertified August, 2015)
PROFESSIONAL SOCIETY MEMBERSHIPS:
American Society of Clinical Oncology
Children's Oncology Group
Publications
Talleur AC, Navid F, Spunt SL, McCarville MB, Wu J, Mao S, Davidoff AM, Neel MD, Krasin MJ. Limited Margin Radiation Therapy for Children and Young Adults With Ewing Sarcoma Achieves High Rates of Local Tumor Control. Int J Radiat Oncol Biol Phys. 2016 Sep 1; 96(1):119-26. View in: PubMed
Green DM, Zhu L, Wang M, Ness KK, Krasin MJ, Bhakta NH, McCarville MB, Srinivasan S, Stokes DC, Srivastava D, Ojha R, Shelton K, Pui CH, Armstrong GT, Mulrooney DA, Metzger M, Spunt SL, Navid F, Davidoff AM, Rao BN, Robison LL, Hudson MM. Pulmonary Function after Treatment for Childhood Cancer. A Report from the St. Jude Lifetime Cohort Study (SJLIFE). Ann Am Thorac Soc. 2016 Sep; 13(9):1575-85. View in: PubMed
Hurley C, McCarville MB, Shulkin BL, Mao S, Wu J, Navid F, Daw NC, Pappo AS, Bishop MW. Comparison of (18) F-FDG-PET-CT and Bone Scintigraphy for Evaluation of Osseous Metastases in Newly Diagnosed and Recurrent Osteosarcoma. Pediatr Blood Cancer. 2016 Aug; 63(8):1381-6. View in: PubMed
Navid F, Herzog CE, Sandoval J, Daryani VM, Stewart CF, Gattuso J, Mandrell B, Phipps S, Chemaitilly W, Sykes A, Davidoff AM, Shulkin BL, Bahrami A, Furman WL, Mao S, Wu J, Schiff D, Rao B, Pappo A. Feasibility of Pegylated Interferon in Children and Young Adults With Resected High-Risk Melanoma. Pediatr Blood Cancer. 2016 Jul; 63(7):1207-13. View in: PubMed
Morris ZS, Guy EI, Francis DM, Gressett MM, Werner LR, Carmichael LL, Yang RK, Armstrong EA, Huang S, Navid F, Gillies SD, Korman A, Hank JA, Rakhmilevich AL, Harari PM, Sondel PM. In Situ Tumor Vaccination by Combining Local Radiation and Tumor-Specific Antibody or Immunocytokine Treatments. Cancer Res. 2016 Jul 1; 76(13):3929-41. View in: PubMed
McCarville MB, Coleman JL, Guo J, Li Y, Li X, Honnoll PJ, Davidoff AM, Navid F. Use of Quantitative Dynamic Contrast-Enhanced Ultrasound to Assess Response to Antiangiogenic Therapy in Children and Adolescents With Solid Malignancies: A Pilot Study. AJR Am J Roentgenol. 2016 May; 206(5):933-9. View in: PubMed
Sreeraman Kumar R, Messina JL, Reed D, Navid F, Sondak VK. Pediatric Melanoma and Atypical Melanocytic Neoplasms. Cancer Treat Res. 2016; 167:331-69. View in: PubMed
Interiano RB, McCarville MB, Wu J, Davidoff AM, Sandoval J, Navid F. Pneumothorax as a complication of combination antiangiogenic therapy in children and young adults with refractory/recurrent solid tumors. J Pediatr Surg. 2015 Sep; 50(9):1484-9. View in: PubMed
Scott JR, Zhou Y, Cheng C, Ward DA, Swanson HD, Molinelli AR, Stewart CF, Navid F, Jeha S, Relling MV, Crews KR. Comparable efficacy with varying dosages of glucarpidase in pediatric oncology patients. Pediatr Blood Cancer. 2015 Sep; 62(9):1518-22. View in: PubMed
Research
- Drug development for pediatric solid tumors
- Ewing sarcoma family of tumors
- Osteosarcoma
- Childhood melanoma
- Therapy-related infertility
